TherapeuticsMD, Inc.SEC Filings
|
|
All SEC filings by TherapeuticsMD, Inc. (TXMD) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 11, 2026 | |
| 10-Q | Quarterly report | View Diff | May 12, 2026 | |
| 10-K/A | Annual report | View Diff | Mar 31, 2026 | |
| NT 10-K | Notice of late annual filing | Mar 31, 2026 | ||
| 10-K | Annual report | View Diff | Mar 30, 2026 | |
| 10-Q | Quarterly report | View Diff | Nov 12, 2025 | |
| ARS | Annual report to shareholders | Nov 3, 2025 | ||
| 10-Q | Quarterly report | View Diff | Aug 12, 2025 | |
| 10-Q | Quarterly report | View Diff | May 13, 2025 | |
| 10-K/A | Annual report | View Diff | Apr 30, 2025 |
Events
| 8-K | Therapeuticsmd Announces Second Quarter 2026 Financial Results | Aug 11, 2026 | ||
| 8-K | Therapeuticsmd Announces First Quarter 2026 Financial Results | May 12, 2026 | ||
| 8-K | Therapeuticsmd Announces Full Year 2025 Financial Results | Mar 30, 2026 | ||
| 8-K | Changes in Registrant'S Certifying Accountant | Jan 20, 2026 | ||
| 8-K | Submission of Matters to a Vote of Security Holders | Dec 16, 2025 | ||
| 8-K | Therapeuticsmd Announces Third Quarter 2025 Financial Results | Nov 12, 2025 | ||
| 8-K | Therapeuticsmd Announces Second Quarter 2025 Financial Results | Aug 12, 2025 | ||
| 8-K | Therapeuticsmd Announces First Quarter 2025 Financial Results | May 13, 2025 | ||
| 8-K | Other Events | Apr 9, 2025 | ||
| 8-K | Therapeuticsmd Announces Full Year 2024 Financial Results | Mar 27, 2025 |
Registrations and Prospectuses
| AW | Withdrawal of amendment | Jun 14, 2024 | ||
| D | 06b | Jul 10, 2023 | ||
| D | $7.00 Mm in Equity / Options / Securities to Be Acquired, Sold $7.00 Mm, 6 Investors | Nov 14, 2022 | ||
| D | $7.00 Mm in Equity / Options / Securities to Be Acquired, Sold $7.00 Mm, 6 Investors | Oct 17, 2022 | ||
| D | $15m in Equity / Options / Securities to Be Acquired, Sold $15m, 6 Investors | Aug 15, 2022 | ||
| SC 14D9/A | Tender offer solicitation | Jul 13, 2022 | ||
| SC TO-T/A | Third party tender offer statement | Jul 13, 2022 | ||
| SC 14D9/A | Tender offer solicitation | Jul 6, 2022 | ||
| SC TO-T/A | Third party tender offer statement | Jul 6, 2022 | ||
| SC 14D9/A | Tender offer solicitation | Jun 28, 2022 |
Proxies
| DEFA14A | Additional proxy soliciting materials | Nov 3, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Nov 3, 2025 | |
| PRE 14A | Preliminary proxy | View Diff | Oct 24, 2025 | |
| DEFA14A | Additional proxy soliciting materials | Oct 25, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Oct 25, 2024 | |
| DEFA14A | Additional proxy soliciting materials | May 17, 2023 | ||
| DEF 14A | Definitive proxy | View Diff | May 17, 2023 | |
| PRE 14A | Preliminary proxy | View Diff | May 1, 2023 | |
| DEFA14A | Additional proxy soliciting materials | May 21, 2021 | ||
| DEFA14A | Additional proxy soliciting materials | Apr 14, 2021 |
Other
| SEC STAFF | SEC staff action: Order | Apr 19, 2021 | ||
| SEC STAFF | SEC staff action: Order | Mar 22, 2021 | ||
| EFFECT | Notice of effectiveness | May 6, 2020 | ||
| SEC STAFF | SEC staff action: Order | Mar 5, 2020 | ||
| SEC STAFF | SEC staff action: Order | Feb 4, 2020 | ||
| CT ORDER | Confidential treatment order | Apr 10, 2019 | ||
| CT ORDER | Confidential treatment order | Dec 12, 2018 | ||
| CT ORDER | Confidential treatment order | Aug 21, 2018 | ||
| UPLOAD | Letter from SEC | Feb 6, 2017 | ||
| CORRESP | Correspondence with SEC | Jan 31, 2017 |
Ownership
| SC 13G/A | Beneficial ownership report | Aug 5, 2026 | ||
| SC 13G | Beneficial ownership report | Apr 6, 2026 | ||
| 4 | Tommy G Thompson | Dec 29, 2025 | ||
| 4 | Tommy G Thompson | Nov 5, 2025 | ||
| 4 | Gail K Naughton | Nov 5, 2025 | ||
| 4 | Cooper C. Collins | Nov 5, 2025 | ||
| 4 | Marlan D Walker | Nov 5, 2025 | ||
| 4 | Tommy G Thompson | Apr 15, 2025 | ||
| 4 | Marlan D Walker | Apr 15, 2025 | ||
| 4 | Marlan D Walker | Apr 10, 2025 |